Population Health Management Market

Population Health Management Market Size, Growth by Component (Software, Services), Mode of Delivery (On-premise, Cloud-based), End User (Healthcare Providers (Hospitals, ACOs), Healthcare Payers, Employer Groups, Government Bodies) - Global Forecasts to 2027

Report Code: HIT 2429 Oct, 2022, by marketsandmarkets.com

Market Size

The global population health management market size is projected to reach USD 53.3 billion by 2027, at a CAGR of 13.9%.

Market Growth

The factors driving market growth include the need to maintain regulatory compliance, rising need to curtail healthcare costs, and growing demand for patient-centric healthcare. However, dearth of skilled IT professionals, and security concerns is challenging the growth of the global population health management market to a certain extent.

Global Population Health Management Market

To know about the assumptions considered for the study, Request for Free Sample Report

Population Health Management Market Dynamics

Drivers: Rising geriatric population and subsequent growth in burden of chronic diseases

The rising geriatric population and subsequent growth in disease burden are expected to impact the healthcare systems in various countries significantly. The impact of the increasing geriatric population is even more pronounced given the growing pressure on governmental budgets, the decline in the number of health personnel in various regions, and the higher incidence of chronic diseases. Some of the important statistics in this regard have been mentioned below:

  • The number of people aged 65 years or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion by 2050, with most of the increase in developing countries (Source: WHO).
  • In the US, the number of people aged over 65 years is expected to double between 2005 and 2030 (Source: National Institute of Aging, Maryland, US).
  • According to the National Council on Aging, approximately 92% of older adults have at least one chronic disease, and 77% have at least two. Four chronic diseases—heart disease, cancer, stroke, and diabetes—cause almost two-thirds of all deaths each year in the US.

With a colossal pool of geriatric individuals requiring health and long-term care services, the healthcare cost per person is expected to increase in many countries. Moreover, with the growing expectations of citizens regarding healthcare services and social care, the burden on healthcare systems across the globe is increasing. In this regard, many strategies are being pursued by stakeholders to control costs while maintaining the quality of care. Population health management is one such approach that could enhance care quality while simultaneously reducing costs. Solutions such as EHR and population health management solutions are being employed to reduce the burden on the overworked healthcare delivery systems in most countries. As a result of these market conditions, the adoption of population health management solutions is increasing globally

Restraints: Data Breach Concerns

In healthcare, approximately one-third of data breaches result in medical identity theft mainly due to a lack of internal control over patient information, lack of top management support, outdated policies and procedures or non-adherence to existing ones, and inadequate personnel training, all of which contribute to the rise in data breaches and medical identity theft cases in the industry. This makes patient confidentiality a major challenge in the healthcare industry.

A major concern with cloud-based population health management solutions is that data hosted by vendors is not as secure as its on-premise counterparts. Patient information is highly sensitive, and a high degree of privacy needs to be maintained to ensure access only to authorized users. Moreover, the digitization of medical/patient information has created greater data risks and liabilities and increased the chance of data breaches. In the US, the HIPAA Journal recorded 616 healthcare data breaches in its 2020 breach list, an increase of 66% over the total number of breaches tracked in 2018. According to a publication from HIPAA Journal, HIPAA-covered companies and business associates paid around USD 13.6 million for HIPAA violations in 2020 and around USD 15.3 million in 2019. Thus, creating a secure communication platform is a major challenge faced by IT vendors catering to the healthcare industry. Thus, the concerns over the security and privacy of sensitive patient information are limiting the adoption of cloud-based population health management solutions.

Opportunities: Increasing focus on value-based medicine

Value-based medicine is redefining healthcare and capturing results-oriented data, and making it usable. Business Intelligence (BI) helps healthcare organizations determine what data they actually need and further helps them to analyze, evaluate, and utilize this data to understand the overall costs versus benefits and gain a competitive advantage. It also enables transparency in all processes to examine every purchase from the standpoint of value, utility, and outcomes.

Moreover, governments, health insurance companies, and healthcare providers seek new opportunities to reduce costs as the current healthcare model is unsustainable across the globe. Besides, the growing volume and availability of healthcare data and the rising need to deliver quality care to patients will increasingly require healthcare organizations to rely on these new methodologies. This will serve as a strategic competency to differentiate themselves from their competitors and take advantage of the growth opportunities. The rapid transition from fee-for-service (FFS) payments to value-based reimbursement models and the key role of analytics in new pay-for-performance models like Accountable Care Organizations (ACOs) will provide an impetus to the growth of the population health management market.

Challenges: Interoperability issues

The lack of interoperability is a major challenge for effective population health management. A critical factor for population health management is engaging patients with meaningful information about their health, including providing them with a summary of the care received, along with information on labs, medications, and images. Such information is particularly important when patients want to engage in shared decision-making with their physicians (regarding a care plan or course of treatment). However, the inability of patients to access their health records affects population health management outcomes.

The lack of interoperability across healthcare settings is also a barrier to advancing population health management. Confronted with poor interoperability, hospitals typically build or license interfaces to import and export data from both, internal and external sources, such as the hospital’s EHR, laboratories, admit/discharge/transfer processes, medical devices, as well as outside laboratories. Thus, a single hospital may employ a few dozen interfaces, while a large health system with many sites may have to employ hundreds or even thousands of interfaces. For care coordination models, far more complicated interfaces will be necessary to accommodate data exchange. These interfaces prove to be expensive and difficult to maintain and require highly skilled technicians for their efficient operation. The health information exchanges employed by hospitals as a solution to interoperability barriers also pose several challenges, including capital-intensive operation as well as technical difficulties in their management.

Software to register the highest growth in the product & service segment of population health management market in 2021.

On the basis of product & service, the software segment to register highest growth. The high growth of this segment can be attributed to its ability to reduce readmissions, enhanced patient engagement, and flexibility of customizations.

Healthcare providers is the largest end user segment by healthcare providers in the population health management market in 2021.

Based on end user, the healthcare providers segment accounted for the largest share in the population health management market during the forecast period. The large share of this segment can be attributed to the growing patient pool, the increasing load on hospitals to integrate and manage patient data, as well as the growing need to improve the affordability and accessibility of healthcare services are propelling the growth of the PHM solutions market for healthcare providers.

North America accounted for the largest share of the population health management market during the forecast period.

North America holds the largest share of the population health management in 2021. Growth in the North American population health management market can be attributed to factors such as stringent regulations, increasing government support for improving healthcare infrastructure, and the presence of leading market players in the region.

Population Health Management Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Population Health Management Market Key Players

This market is dominated by a few globally established players such as Cerner Corporation (US), Epic Systems Corporation (US), Koninklijke Philips (Netherlands), i2i Population Health (US), Health Catalyst (US), Optum (US), Enli Health Intelligence (US), eClinicalWorks (US), Allscripts Healthcare Solutions (US), IBM Corporation (US), HealthEC LLC (US), Medecision (US), Arcadia (US), athenahealth (US), Cotiviti (US), NextGen Healthcare, Inc. (US), Conifer Health Solutions (US), SPH Analytics (US), Lightbeam Health Solutions (US), Innovaccer (US), Lumeris (US), Zeomega (US), HGS Healthcare, LLC (US), Persivia (US) and Color Health, Inc.(US).

Scope of the Population Health Management Market Report

Report Metric

Details

Market Size by 2027

USD 53.3 billion

CAGR

13.9%

Forecast to

2027

Forecast Units

Value (USD billion)

Segments Covered

By Component, Mode of delivery, End user, and region

Geographies Covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

The study categorizes the global population health management market based on components, delivery mode, end user at regional and global level.

By Product & Service

  • Introduction
  • Software
  • Services

By Mode of Delivery

  • Introduction
  • On-premise
  • Cloud-based

By End User

  • Introduction
  • Healthcare Providers
  • Healthcare Payers
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In September 2022, i2i Population Health (US) entered into a partnership with Tennessee Primary Care Association (TPCA) (US) to leverage i2i’s PRiZiM network PHM platform to share best practices and improve care through their Center for Quality in Community Health (CQCH).
  • In June 2022, eClinicalWorks (US) partnered with Witham Health Services (US) to further improve patient communications and achieve overall operational efficiency in more than 30 locations of the nonprofit healthcare organization.
  • In March 2022, Arcadia (US)) collaborated with Rush Health (US) leverage Arcadia’s HITRUST CSF-certified population health management platform to unite four hospitals, 140 practices and 2,300 providers and implement a quality improvement program that has enhanced care and financial value through better performance in fee-for-value payment models covering more than 150,000 patients.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 24)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 POPULATION HEALTH MANAGEMENT MARKET
                    FIGURE 2 REGIONAL SEGMENTS COVERED
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED
          TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
    1.4 STAKEHOLDERS
    1.5 LIMITATIONS
    1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH DATA
          FIGURE 3 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 4 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Insights from primary experts
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
                                FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
           2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
                    FIGURE 7 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS)
                    FIGURE 8 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
           2.2.2 APPROACH 2: TOP-DOWN APPROACH (SUPPLY SIDE ANALYSIS)
                    FIGURE 9 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 RESEARCH ASSUMPTIONS
    2.5 RISK ASSESSMENT
          TABLE 2 RISK ASSESSMENT: POPULATION HEALTH MANAGEMENT MARKET

3 EXECUTIVE SUMMARY (Page No. - 40)
    FIGURE 11 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHICAL SNAPSHOT

4 PREMIUM INSIGHTS (Page No. - 44)
    4.1 POPULATION HEALTH MANAGEMENT MARKET OVERVIEW
          FIGURE 15 NEED TO CURTAIL ESCALATING HEALTHCARE COSTS TO DRIVE MARKET
    4.2 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER AND COUNTRY (2021)
          FIGURE 16 JAPAN DOMINATED ASIA PACIFIC MARKET IN 2021
    4.3 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
          FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 REGIONAL MIX: POPULATION HEALTH MANAGEMENT MARKET (2022−2027)
          FIGURE 18 NORTH AMERICA TO DOMINATE GLOBAL MARKET DURING FORECAST PERIOD
    4.5 POPULATION HEALTH MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS
          FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          TABLE 3 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: IMPACT ANALYSIS
          FIGURE 20 POPULATION HEALTH MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Government mandates and support for healthcare IT solutions
                    5.2.1.2 Need to curtail escalating healthcare costs
                                FIGURE 21 US HEALTHCARE SPENDING, 2012–2020 (USD BILLION)
                    5.2.1.3 Rising geriatric population and subsequent growth in chronic disease burden
           5.2.2 RESTRAINTS
                    5.2.2.1 High investments in infrastructure to set up robust PHM program
                    5.2.2.2 Rising data breach concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing importance of emerging markets in healthcare sector
                    5.2.3.2 Rising focus on personalized medicine
                    5.2.3.3 Increasing focus on value-based medicine
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of data management capabilities and skilled analysts
                    5.2.4.2 Interoperability issues

6 INDUSTRY INSIGHTS (Page No. - 57)
    6.1 INDUSTRY TRENDS
           6.1.1 NEED FOR INTEROPERABILITY AND INTEGRATION TO DRIVE INNOVATION
           6.1.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
           6.1.3 GROWING DEMAND FOR PATIENT-CENTRIC HEALTHCARE
                    FIGURE 22 VALUE-BASED CARE WORKFLOW
           6.1.4 CLOUD-BASED IT SOLUTIONS
           6.1.5 CONSOLIDATION OF HEALTHCARE PROVIDERS
    6.2 ECOSYSTEM ANALYSIS
        FIGURE 23 POPULATION HEALTH MANAGEMENT MARKET: ECOSYSTEM ANALYSIS
    6.3 EVOLUTION OF ACOS: A PROMISING PAYMENT REFORM
           6.3.1 INTRODUCTION
                    FIGURE 24 ACOS: REIMBURSEMENT MODEL
           6.3.2 US: EVOLUTION OF ACOS
                    FIGURE 25 EVOLUTION OF ACO MODELS
           6.3.3 ROLE OF INFORMATION TECHNOLOGY IN ACCOUNTABLE CARE
                    FIGURE 26 ACCOUNTABLE CARE SOLUTIONS AND THEIR USE
    6.4 HCIT EXPENDITURE ANALYSIS
           6.4.1 NORTH AMERICA
                    TABLE 4 NORTH AMERICA: HEALTHCARE EXPENDITURE, BY COUNTRY
           6.4.2 EUROPE
           6.4.3 ASIA PACIFIC
                    TABLE 5 JAPAN: HEALTHCARE IT INITIATIVES AND FUNDING
                    TABLE 6 CHINA: HEALTHCARE IT INITIATIVES AND FUNDING
    6.5 REGULATORY ANALYSIS
           6.5.1 NORTH AMERICA
           6.5.2 EUROPE
           6.5.3 ASIA PACIFIC
    6.6 PORTER’S FIVE FORCES ANALYSIS
          FIGURE 27 DEGREE OF COMPETITION TO BE HIGH IN POPULATION HEALTH MANAGEMENT MARKET
          TABLE 7 POPULATION HEALTH MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
    6.7 PATENT ANALYSIS
          FIGURE 28 TOP PATENT OWNERS AND APPLICANTS FOR POPULATION HEALTH MANAGEMENT SOLUTIONS (JANUARY 2011–SEPTEMBER 2022)
          FIGURE 29 PATENT ANALYSIS: POPULATION HEALTH MANAGEMENT MARKET (JANUARY 2017–SEPTEMBER 2022)
    6.8 ADJACENT MARKET ANALYSIS
          FIGURE 30 PATIENT REGISTRY SOFTWARE MARKET: MARKET OVERVIEW
          FIGURE 31 AMBULATORY EHR MARKET: MARKET OVERVIEW
    6.9 CASE STUDY
    6.10 KEY STAKEHOLDERS AND BUYING CRITERIA
           6.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS
                     TABLE 8 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR DEPLOYMENT MODES (%)
           6.10.2 BUYING CRITERIA
                     FIGURE 33 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
                     TABLE 9 KEY BUYING CRITERIA FOR DEPLOYMENT MODES
    6.11 KEY CONFERENCES AND EVENTS (2022-2023)
    6.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           FIGURE 34 REVENUE SHIFT IN POPULATION HEALTH MANAGEMENT MARKET
    6.13 PRICING ANALYSIS
           6.13.1 INITIAL FEES
                     TABLE 10 PRE-ELEMENT FEE FOR PHM SOLUTIONS
           6.13.2 ANNUAL MAINTENANCE FEES
                     TABLE 11 ANNUAL MAINTENANCE FEE FOR PHM SOLUTIONS
    6.14 TECHNOLOGY ANALYSIS
           6.14.1 INTEGRATION OF AI AND ML
           6.14.2 DATA ANALYTICS

7 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT (Page No. - 80)
    7.1 INTRODUCTION
          TABLE 12 POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
    7.2 SOFTWARE
           7.2.1 SOFTWARE TO DOMINATE COMPONENT SEGMENT
                    TABLE 13 POPULATION HEALTH MANAGEMENT SOFTWARE OFFERED BY KEY PLAYERS
                    TABLE 14 POPULATION HEALTH MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 SERVICES
           7.3.1 INDISPENSABLE AND RECURRING NATURE OF SERVICES TO PROPEL MARKET
                    TABLE 15 POPULATION HEALTH MANAGEMENT SERVICES OFFERED BY KEY PLAYERS
                    TABLE 16 POPULATION HEALTH MANAGEMENT SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY (Page No. - 88)
    8.1 INTRODUCTION
          TABLE 17 POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
    8.2 ON-PREMISE MODE OF DELIVERY
           8.2.1 TRADITIONAL ON-PREMISE DEPLOYMENT TO ALLOW TIME TO TEST SOFTWARE UPGRADES BEFORE IMPLEMENTATION
                    TABLE 18 ON-PREMISE MODE OF DELIVERY: PROS AND CONS
                    TABLE 19 POPULATION HEALTH MANAGEMENT MARKET FOR ON-PREMISE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 CLOUD-BASED MODE OF DELIVERY
           8.3.1 CLOUD-BASED DELIVERY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
                    TABLE 20 CLOUD-BASED MODE OF DELIVERY: PROS AND CONS
                    TABLE 21 POPULATION HEALTH MANAGEMENT MARKET FOR CLOUD-BASED SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)

9 POPULATION HEALTH MANAGEMENT MARKET, BY END USER (Page No. - 93)
    9.1 INTRODUCTION
          TABLE 22 POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.2 HEALTHCARE PROVIDERS
           9.2.1 NEED TO IMPROVE PROFITABILITY OF HEALTHCARE OPERATIONS TO BOOST MARKET
                    TABLE 23 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.3 HEALTHCARE PAYERS
           9.3.1 INCREASED FOCUS ON OUTCOME-BASED PAYMENT MODELS TO STIMULATE DEMAND FOR PHM SOLUTIONS
                    TABLE 24 POPULATION HEALTH MANAGEMENT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
    9.4 OTHER END USERS
          TABLE 25 POPULATION HEALTH MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

10 POPULATION HEALTH MANAGEMENT MARKET, BY REGION (Page No. - 99)
     10.1 INTRODUCTION
             TABLE 26 POPULATION HEALTH MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             FIGURE 35 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
             TABLE 27 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 28 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 29 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 30 NORTH AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.1 US
                        10.2.1.1 US to dominate North American market during forecast period
                                      TABLE 31 US: MACROECONOMIC INDICATORS
                                      TABLE 32 US: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 33 US: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 34 US: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.2.2 CANADA
                        10.2.2.1 Deployment of digital health initiatives to boost market
                                      TABLE 35 CANADA: MACROECONOMIC INDICATORS
                                      TABLE 36 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 37 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 38 CANADA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.3 EUROPE
             TABLE 39 EUROPE: E-HEALTH PRIORITIES FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2019
             TABLE 40 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 41 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 42 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 43 EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.1 GERMANY
                        10.3.1.1 Germany to dominate European population health management market
                                      TABLE 44 GERMANY: MACROECONOMIC INDICATORS
                                      TABLE 45 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 46 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 47 GERMANY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.2 UK
                        10.3.2.1 Increasing public-private initiatives to support adoption of PHM solutions
                                      TABLE 48 UK: MACROECONOMIC INDICATORS
                                      TABLE 49 UK: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 50 UK: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 51 UK: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.3 FRANCE
                        10.3.3.1 Increasing patient volume for chronic and age-related conditions to fuel market
                                      TABLE 52 FRANCE: MACROECONOMIC INDICATORS
                                      TABLE 53 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 54 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 55 FRANCE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.4 ITALY
                        10.3.4.1 Government initiatives to support market
                                      TABLE 56 ITALY: MACROECONOMIC INDICATORS
                                      TABLE 57 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 58 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 59 ITALY: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.5 SPAIN
                        10.3.5.1 Demand for e-prescriptions and better patient record management to drive adoption of PHM solutions
                                      TABLE 60 SPAIN: MACROECONOMIC INDICATORS
                                      TABLE 61 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 62 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 63 SPAIN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.3.6 REST OF EUROPE
                        TABLE 64 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 65 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 66 REST OF EUROPE: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             FIGURE 36 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET SNAPSHOT
             TABLE 67 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 68 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 69 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
             TABLE 70 ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.1 JAPAN
                        10.4.1.1 Japan accounted for largest share of Asia Pacific market in 2021
                                      TABLE 71 JAPAN: MACROECONOMIC INDICATORS
                                      TABLE 72 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 73 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 74 JAPAN: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Strong government support to propel market
                                      TABLE 75 CHINA: MACROECONOMIC INDICATORS
                                      TABLE 76 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 77 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 78 CHINA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.3 INDIA
                        10.4.3.1 Growing volume of patient data generated within healthcare systems to drive market
                                      TABLE 79 INDIA: MACROECONOMIC INDICATORS
                                      TABLE 80 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 81 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                                      TABLE 82 INDIA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
             10.4.4 REST OF ASIA PACIFIC
                        TABLE 83 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 84 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 85 REST OF ASIA PACIFIC: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 BRAZIL, ARGENTINA, AND MEXICO TO EMERGE AS POTENTIAL HEALTHCARE MARKETS
                        TABLE 86 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 87 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 88 LATIN AMERICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE TO PROPEL MARKET
                        TABLE 89 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 90 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY MODE OF DELIVERY, 2020–2027 (USD MILLION)
                        TABLE 91 MIDDLE EAST & AFRICA: POPULATION HEALTH MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 138)
     11.1 INTRODUCTION
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             FIGURE 37 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2019 AND AUGUST 2022
     11.3 POPULATION HEALTH MANAGEMENT MARKET: R&D EXPENDITURE
             FIGURE 38 R&D EXPENDITURE OF KEY PLAYERS (2020 VS. 2021)
     11.4 REVENUE ANALYSIS OF KEY PLAYERS
             FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS (2021)
     11.5 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
             FIGURE 40 POPULATION HEALTH MANAGEMENT MARKET: GEOGRAPHIC REVENUE MIX
     11.6 COMPANY EVALUATION QUADRANT
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 41 COMPETITIVE LEADERSHIP MAPPING, 2020
     11.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 RESPONSIVE COMPANIES
             11.7.3 DYNAMIC COMPANIES
             11.7.4 STARTING BLOCKS
                        FIGURE 42 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES
     11.8 KEY PLAYERS ANALYSIS
             TABLE 92 POPULATION HEALTH MANAGEMENT MARKET ANALYSIS, BY VENDOR TYPE
     11.9 COMPETITIVE SITUATIONS AND TRENDS
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 151)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 CERNER CORPORATION
                        TABLE 93 CERNER CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.2 ALLSCRIPTS HEALTHCARE SOLUTIONS
                        TABLE 94 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY OVERVIEW
                        FIGURE 44 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: COMPANY SNAPSHOT (2021)
             12.1.3 IBM CORPORATION
                        TABLE 95 IBM CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 IBM CORPORATION: COMPANY SNAPSHOT (2021)
             12.1.4 EPIC SYSTEMS CORPORATION
                        TABLE 96 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
             12.1.5 KONINKLIJKE PHILIPS
                        TABLE 97 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 46 PHILLIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
             12.1.6 I2I POPULATION HEALTH
                        TABLE 98 I2I POPULATION HEALTH: COMPANY OVERVIEW
             12.1.7 HEALTH CATALYST
                        TABLE 99 HEALTH CATALYST: COMPANY OVERVIEW
                        FIGURE 47 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
             12.1.8 OPTUM INC. (A SUBSIDIARY OF UNITEDHEALTH GROUP)
                        TABLE 100 OPTUM, INC: COMPANY OVERVIEW
                        FIGURE 48 OPTUM: COMPANY SNAPSHOT (2021)
             12.1.9 ENLI HEALTH INTELLIGENCE (A CEDAR GROUP TECHNOLOGIES)
                        TABLE 101 ENLI HEALTH INTELLIGENCE: COMPANY OVERVIEW
             12.1.10 ECLINICALWORKS
                        TABLE 102 ECLINICALWORKS: COMPANY OVERVIEW
             12.1.11 HEALTHEC, LLC
                        TABLE 103 HEALTHEC LLC: COMPANY OVERVIEW
             12.1.12 MEDECISION
                        TABLE 104 MEDECISION: COMPANY OVERVIEW
             12.1.13 ARCADIA
                        TABLE 105 ARCADIA: COMPANY OVERVIEW
             12.1.14 ATHENAHEALTH
                        TABLE 106 ATHENAHEALTH, INC: COMPANY OVERVIEW
             12.1.15 COTIVITI (VERSCEND TECHNOLOGIES)
                        TABLE 107 COTIVITI: COMPANY OVERVIEW
             12.1.16 NEXTGEN HEALTHCARE, INC.
                        TABLE 108 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
                        FIGURE 49 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2021)
     12.2 OTHER PLAYERS
             12.2.1 CONIFER HEALTH SOLUTIONS
             12.2.2 SPH ANALYTICS
             12.2.3 LIGHTBEAM HEALTH SOLUTIONS
             12.2.4 INNOVACCER
             12.2.5 LUMERIS
             12.2.6 ZEOMEGA
             12.2.7 HGS HEALTHCARE, LLC
             12.2.8 PERSIVIA
             12.2.9 COLOR HEALTH, INC.

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 199)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This research study involved the extensive use of both primary and secondary sources. Various factors affecting the industry were studied to identify segmentation types; industry trends; key players; the competitive landscape of the market; and key market dynamics, such as drivers, restraints, opportunities, challenges, and key player strategies.

Secondary Research

This research study involved secondary sources; directories; databases such as Bloomberg Business and Factiva; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the population health management market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information. The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, marketing managers, regional/area sales managers, product managers, distributors, business development managers, technology & innovation directors of population health management software solutions providers, KOLs, and suppliers & distributors. Primary sources from the demand side include industry experts such as directors of hospitals, ambulatory surgical centers, healthcare payers, and healthcare providers.

A breakdown of the primary respondents is provided below:

Population Health Management Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 =

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the population health management market was arrived at after data triangulation from five different approaches, as mentioned below. After each approach, the weighted average of approaches was taken based on the level of assumptions used.

Data Triangulation

The individual share of each segment was arrived at by assigning weightages based on their utilization rate. The regional splits of the market and its subsegments are based on the adoption or utilization rates of the given solutions in the respective regions or countries. For countries with the limited availability of reliable and recent data, the analogy/benchmarking-based market estimation and forecast technique was used.

Global Population health management Market Size: Top-Down Approach

Population Health Management Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Objectives of the Study

  • To define, describe, and forecast the size of the population health management market on the basis of component, mode of delivery, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall population health management market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically analyze the market structure and profile the key players in the population health management market and comprehensively analyze their core competencies2
  • To track and analyze company developments such as agreements, collaborations, partnerships, acquisitions, expansions, and solution launches & enhancements in the population health management market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific market into Australia, South Korea, New Zealand, Hong Kong, Singapore, and other countries
  • Further breakdown of the Rest of Europe market into Russia, Switzerland, the Netherlands, Nordic countries, and other countries
Report Code
HIT 2429
Published ON
Oct, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Population Health Management Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback